U.S. markets closed

Kiora Pharmaceuticals, Inc. (KPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.5896-0.0004 (-0.07%)
At close: 03:59PM EST
0.5820 -0.01 (-1.29%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close0.5900
Bid0.5850 x 900
Ask0.6000 x 43500
Day's Range0.5650 - 0.6090
52 Week Range0.4620 - 5.2500
Avg. Volume1,597,690
Market Cap4.534M
Beta (5Y Monthly)-0.36
PE Ratio (TTM)0.76
EPS (TTM)0.7800
Earnings DateMar 21, 2024 - Mar 25, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for KPRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Kiora Pharmaceuticals, Inc.
    Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverIn this edition, global oil inventories face future; feeling the internet's backbone; and initiating coverage of Qualys; and Lithium Americas, Bausch & Lomb and Macy's.
    Fair Value
    Economic Moat
    11 months agoMorningstar
View more